8-99977931-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_015668.5(RGS22):c.3505G>A(p.Glu1169Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000039 in 1,562,326 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015668.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RGS22 | NM_015668.5 | c.3505G>A | p.Glu1169Lys | missense_variant | 23/28 | ENST00000360863.11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RGS22 | ENST00000360863.11 | c.3505G>A | p.Glu1169Lys | missense_variant | 23/28 | 1 | NM_015668.5 | P3 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152158Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000544 AC: 11AN: 202332Hom.: 0 AF XY: 0.0000810 AC XY: 9AN XY: 111106
GnomAD4 exome AF: 0.0000418 AC: 59AN: 1410168Hom.: 0 Cov.: 29 AF XY: 0.0000400 AC XY: 28AN XY: 700424
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152158Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74340
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 14, 2022 | The c.3505G>A (p.E1169K) alteration is located in exon 23 (coding exon 23) of the RGS22 gene. This alteration results from a G to A substitution at nucleotide position 3505, causing the glutamic acid (E) at amino acid position 1169 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at